New Delhi, Oct. 17 -- The Supreme Court on Friday rejected Swiss pharmaceutical giant F. Hoffmann-La Roche AG's (Roche) plea seeking that Natco Pharma Ltd be restricted from selling the generic version of its life-saving spinal muscular atrophy (SMA) drug, Risdiplam, in India until the conclusion of the case.

The bench of Justices P.S. Narasimha and A.S. Chandurkar declined to interfere with a 9 October Delhi high court division bench ruling that had upheld a March single-judge order denying Roche an injunction.

The top court also rejected Roche's plea to bar Natco from exporting the drug but asked the Delhi high court to expedite the hearing.

"We are not inclined to interfere with the order passed by the high court for the reason that...